AI is a key technological enabler of aging research and the only hope to move the longevity progress fast enough for the existing generation to live longer than nature currently permits.
Helping people live healthier lives for longer is not only a nobel altruistic goal in its own right, but it is also a growing economical and societal necessity. For example, according to the U.S. Census Bureau, a not-so-distant 2030 will be a milestone year in which older people will actually outnumber children for the first time in history. Census Bureau data also estimates that 1 in every 5 Americans will reach retirement age by that time. The phenomenon of a rapidly aging human population is often referred to as “The Silver Tsunami”, and it will have increasingly significant impact on everyday life, the economy and society — rapidly rising healthcare costs, infrastructural and service demands, the compounding loss of accumulated skills and competencies when people retire and become non-functional, and so on.
The only sustainable strategy to manage a rapidly aging population is to increase the “healthspan” — a period of human life when there are little or no effects of age-related diseases and conditions, and the human beings can function efficiently, perform work duties, enjoy life, etc. In this sense, the increase of healthspan is even more important, in practical terms than the increase of the overall lifespan — although both usually correlate.
More and more scientists, businesses, investors, non-government organizations and associations, as well as governments themselves are concerned with the increasing issue of an aging population. This led to the emergence of the Longevity industry, a fairly new notion describing intricately complex activities linking science, medicine, economy, and societal trends, all aimed at increasing the health- and lifespan of the human population.
Read More at Bio Pharma Trend
Read the rest at Bio Pharma Trend